Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
4 hedge funds and large institutions have $95K invested in Altamira Therapeutics Ltd in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
79% less capital invested
Capital invested by funds: $443K → $95K (-$348K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$9.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$101K |
| 2 |
Renaissance Technologies
New York
|
-$74K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$36K |
| 4 |
Morgan Stanley
New York
|
-$13.8K |
| 5 |
JP Morgan Chase
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $72K | -$101K | -206 | -48% |
|
|
2
Morgan Stanley
New York
| $12K | -$13.8K | -28 | -43% |
|
|
3
UBS Group
Zurich,
Switzerland
| $6K | +$9.36K | +19 | New |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | – | – | – |
|
|
5
Renaissance Technologies
New York
| – | -$74K | -114 | Closed |
|
|
WS
6
Wedbush Securities
Los Angeles,
California
| – | -$36K | -55 | Closed |
|
|
7
JP Morgan Chase
New York
| – | -$3K | -5 | Closed |
|
CYTO Hedge Fund Activity: Q1 2020 in Review
4 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q1 2020, worth a combined $95K — down 79% from $443K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CYTO and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $9.36K. The largest seller was Sabby Management, cutting an estimated $101K.
- 4 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q1 2020, down from 6 in Q4 2019.
- Funds reported $95K of Altamira Therapeutics Ltd stock for Q1 2020, down 79% quarter-over-quarter.
- 1 fund opened new Altamira Therapeutics Ltd positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest Altamira Therapeutics Ltd buyer in Q1 2020 was UBS Group, an estimated $9.36K added.
- The largest Altamira Therapeutics Ltd seller in Q1 2020 was Sabby Management, an estimated $101K sold.
Based on aggregated 13F filings for Q1 2020.